Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Garima
    Garima

      Garima joined Medical Dialogues in the year 2017 and is currently working as a Senior Editor. She looks after all the Healthcare news pertaining to Medico-legal cases, MCI/DCI decisions, Medical Education issues, government policies as well as all the news and updates concerning Medical and Dental Colleges in India. She is a graduate from Delhi University. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      • Home
      • Garima

      Articles By : Garima

      Exceptional Losses: Fortis reports consolidated net loss of Rs 180 crore for December quarter

      Exceptional Losses: Fortis reports consolidated net loss of Rs 180 crore for December quarter

      Garima15 Feb 2019 12:41 PM IST
      Commenting on the results, Fortis Healthcare Chairman Ravi Rajagopal said the last quarter witnessed the reconstitution of the Board, with the...
      Sun Pharma Q3 profit rises 49 percent at Rs 1242 crore

      Sun Pharma Q3 profit rises 49 percent at Rs 1242 crore

      Garima15 Feb 2019 9:45 AM IST
      "We remain committed towards executing our global speciality strategy, strengthening core operations and enhancing overall efficiencies," said...
      Dr Agarwal Group raises Rs 270 crore from Temasek to double eye hospitals

      Dr Agarwal Group raises Rs 270 crore from Temasek to double eye hospitals

      Garima14 Feb 2019 11:38 AM IST
      New Delhi: Temasek, a Singapore headquartered global investor has infused Rs 270 crore ($38 million) into Dr Agarwal’s Health Care Ltd, as it...
      Natco Pharma shares decline nearly 5 percent after Q3 results

      Natco Pharma shares decline nearly 5 percent after Q3 results

      Garima14 Feb 2019 9:05 AM IST
      "The decline in profits during the quarter compared to last year was predominantly due to margin reduction of Oseltamivir in the USA market," Natco...
      Aurobindo Pharma acquires Apotexs businesses in 5 European countries

      Aurobindo Pharma acquires Apotex's businesses in 5 European countries

      Garima12 Feb 2019 9:30 AM IST
      Aurobindo Pharma had inked a binding agreement on July 14, 2018, to acquire five of Apotex' European businesses, including infrastructure, personnel,...
      Apollo Hospitals Q3 profit rises 29 percent to Rs 86 crore on higher revenues

      Apollo Hospitals Q3 profit rises 29 percent to Rs 86 crore on higher revenues

      Garima12 Feb 2019 9:15 AM IST
      Apollo Hospitals on Saturday said that it plans to transfer the front-end retail pharmacy business carried out in the standalone pharmacy segment to a...
      HCG to increase stake in BACC Healthcare; stocks gain 2%

      HCG to increase stake in BACC Healthcare; stocks gain 2%

      Garima11 Feb 2019 4:06 PM IST
      Shares of HealthCare Global Enterprises (HCG) gained 2% on Friday after the company, in its filing to the exchanges, informed that it will increase...
      Cipla completes 1st tranche of acquisition in US-based Avenue Therapeutics

      Cipla completes 1st tranche of acquisition in US-based Avenue Therapeutics

      Garima11 Feb 2019 9:58 AM IST
      Drug major Cipla said its subsidiary InvaGen Pharmaceuticals Inc has completed the first tranche of its acquisition of 33.3 percent stake in US-based...
      Abbott India Q3 net profit rises at Rs 117 crore, revenue rises to Rs 947 crore

      Abbott India Q3 net profit rises at Rs 117 crore, revenue rises to Rs 947 crore

      Garima10 Feb 2019 9:30 AM IST
      Abbott India had posted a net profit of Rs 115.39 crore for the corresponding period of the previous financial year, Abbott India said in a filing to...
      Aurobindo Pharma Q3 profit rises 19.69 percent to Rs 712 crore on robust sales

      Aurobindo Pharma Q3 profit rises 19.69 percent to Rs 712 crore on robust sales

      Garima9 Feb 2019 9:30 AM IST
      Commenting on the results, Aurobindo Pharma MD N Govindarajan said: "We have delivered robust revenue growth of 22 per cent, driven by strong growth...
      Cadila Healthcare Q3 profit falls 6 percent to Rs 511 crore on rising expenses

      Cadila Healthcare Q3 profit falls 6 percent to Rs 511 crore on rising expenses

      Garima8 Feb 2019 11:35 AM IST
      Cadila Healthcare had posted a net profit of Rs 543.3 crore in the corresponding period of the previous fiscal, the drug firm said in a filing to...
      BMC unveils Rs 30692 crore budget for the fiscal year 2019-20

      BMC unveils Rs 30692 crore budget for the fiscal year 2019-20

      Garima5 Feb 2019 10:00 AM IST
      Mumbai: The Brihanmumbai Municipal Corporation(BMC), Asia's wealthiest civic body has recently announced the budget for the financial year 2019-20....
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok